Mounjaro vs Wegovy. They are two of the most widely discussed prescription weight-management injections in Europe.

Both are used alongside a reduced-calorie diet and increased physical activity in eligible people living with obesity or overweight with weight-related health conditions. However, they contain different active ingredients and work in different ways.

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors.

Wegovy contains semaglutide, which acts as a GLP-1 receptor agonist.

For people researching medical weight-loss treatment, the question is often not simply “which is stronger?” but rather which treatment is suitable for my health, preferences and circumstances?

You can browse the current MySlimCare weight loss injection range or view the full MySlimCare shop.

What Is Mounjaro?

Mounjaro is a prescription medicine containing tirzepatide.

It is authorised in the European Union for both type 2 diabetes and weight management under specified conditions.

For weight management, Mounjaro is used alongside diet and physical activity in adults with:

BMI of 30kg/m² or above, or
BMI of 27kg/m² to below 30kg/m² with at least one weight-related health condition.

Examples of qualifying weight-related conditions can include:

high blood pressure;
abnormal blood lipid levels;
obstructive sleep apnoea;
cardiovascular disease;
prediabetes; and
type 2 diabetes.

Mounjaro is administered by subcutaneous injection once weekly.

Explore Weight Loss Injections

What Is Wegovy?

Wegovy is a prescription weight-management medicine containing semaglutide.

It is authorised in the EU for adults with:

BMI of 30kg/m² or higher, or
BMI of at least 27kg/m² but below 30kg/m² with at least one weight-related health condition.

Wegovy is also authorised for certain adolescents aged 12 years and above who meet specific obesity and weight criteria.

The established injectable formulation is used once weekly.

Semaglutide acts on GLP-1 receptors involved in appetite regulation and food intake.

Mounjaro vs Wegovy at a Glance

Feature	Mounjaro	Wegovy
Active ingredient	Tirzepatide	Semaglutide
Main receptor activity	GIP + GLP-1	GLP-1
Administration	Weekly injection	Weekly injection
EU weight-management approval	Yes	Yes
Diet and exercise required	Yes	Yes
Prescription required	Yes	Yes
Appetite regulation	Yes	Yes
Also authorised for type 2 diabetes	Yes	Semaglutide has separate diabetes products, but Wegovy itself is a weight-management brand
Suitable for everyone?	No	No

How Does Mounjaro Work?

Tirzepatide acts on two hormone pathways:

glucose-dependent insulinotropic polypeptide, or GIP;
glucagon-like peptide-1, or GLP-1.

These pathways are involved in processes including:

appetite regulation;
food intake;
insulin secretion;
glucose metabolism; and
feelings of fullness.

By activating both receptors, tirzepatide can help reduce hunger and calorie intake while supporting metabolic regulation.

This dual mechanism is the main scientific distinction between Mounjaro and Wegovy.

How Does Wegovy Work?

Semaglutide acts as a GLP-1 receptor agonist.

GLP-1 is naturally involved in appetite control and satiety.

By activating GLP-1 receptors, semaglutide can help:

increase feelings of fullness;
reduce hunger;
reduce food intake; and
support a sustained calorie deficit.

Wegovy is used as part of a broader weight-management programme rather than as a substitute for diet or physical activity.

Is Mounjaro More Effective Than Wegovy?

This is one of the most searched questions about the two medicines. Mounjaro vs Wegovy.

Mounjaro has produced substantial average weight loss in clinical studies.

EMA reports that in a study involving more than 2,500 adults with obesity or overweight plus at least one related health condition, people using Mounjaro alongside diet and physical activity lost at least 15% of body weight on average depending on the dose over 72 weeks, compared with around 3% with placebo.

Wegovy has also demonstrated clinically significant weight reduction in its development programme and remains an authorised weight-management treatment in Europe.

However, comparing headline percentages between different trials can be misleading because studies may differ in:

population;
duration;
dose;
trial design;
dietary programme;
baseline weight; and
statistical methods.

Therefore, Mounjaro should not automatically be described as “better” for every patient.

Tirzepatide vs Semaglutide: What Is the Main Difference?

The major difference lies in receptor activity.

Tirzepatide

Tirzepatide activates both GIP and GLP-1 receptors.

Semaglutide

Semaglutide primarily activates GLP-1 receptors.

Both mechanisms can influence appetite and weight management, but they are not identical medicines.

This also means their:

dosing schedules;
side-effect profiles;
contraindications;
treatment responses; and
individual suitability

may differ.

Mounjaro vs Wegovy Dosage

Both medicines use gradual dose escalation.

Patients do not normally start treatment at the highest available dose.

Dose escalation helps the body adjust and can reduce the severity of gastrointestinal side effects. Mounjaro vs Wegovy.

The exact starting dose and escalation schedule should always follow the current prescribing information and professional guidance.

Do not increase the dose yourself because you want faster weight loss.

How Often Are Mounjaro and Wegovy Injected?

Both established injectable treatments are normally administered once weekly.

This means they may be more convenient for some patients than medicines requiring daily dosing.

Choosing the same day each week can help maintain a consistent routine.

Which Causes More Weight Loss: Mounjaro vs Wegovy?

Clinical results suggest that both can produce substantial weight reduction in eligible patients.

However, a patient should not select treatment solely according to the highest average percentage reported online.

Factors affecting personal results include:

starting body weight;
dose reached;
duration of treatment;
diet;
exercise;
treatment adherence;
underlying health conditions; and
individual biology.

No healthcare provider should guarantee a specific amount of weight loss from either medicine. Mounjaro vs Wegovy.

Mounjaro vs Wegovy Side Effects

Both treatments commonly cause gastrointestinal side effects.

Common Mounjaro Side Effects

EMA lists common tirzepatide effects including:

nausea;
diarrhoea;
constipation; and
vomiting.

These effects may be more noticeable during dose escalation.

Common Wegovy Side Effects

GLP-1 receptor agonists including semaglutide are also associated with gastrointestinal effects such as:

nausea;
diarrhoea;
vomiting;
constipation; and
abdominal symptoms.

Side effects differ from person to person.

Which Has Fewer Side Effects?

There is no universal answer.

One person may tolerate tirzepatide better, while another may tolerate semaglutide better. Mounjaro vs Wegovy.

Factors influencing tolerability include:

dose;
speed of escalation;
eating habits;
hydration;
medical history; and
individual sensitivity.

Treatment should be adjusted or reconsidered when side effects are significant.

Can Mounjaro or Wegovy Cause Serious Side Effects?

Both medicines have warnings and precautions beyond common gastrointestinal symptoms.

Patients should read the current product leaflet and seek medical advice if they develop severe or persistent symptoms.

Potentially serious concerns with incretin-based medicines can include conditions involving:

the pancreas;
gallbladder;
dehydration;
severe gastrointestinal symptoms; or
allergic reactions.

The precise risk profile differs between products.

Who Should Not Take Mounjaro or Wegovy?

Neither medicine is suitable for everyone. Mounjaro vs Wegovy.

Suitability may be affected by:

pregnancy;
breastfeeding;
certain gastrointestinal conditions;
pancreatic history;
gallbladder disease;
kidney problems;
other medicines;
previous drug reactions; and
other individual medical factors.

A full consultation is important before treatment.

Mounjaro vs Wegovy During Pregnancy

Weight-loss medicines are generally not intended for use during pregnancy.

Anyone who is:

pregnant;
planning pregnancy;
potentially pregnant; or
breastfeeding

should disclose this before beginning treatment.

Follow the specific product guidance for discontinuation timing before planned pregnancy. Mounjaro vs Wegovy.

Can You Switch From Wegovy to Mounjaro?

In some cases, a healthcare professional may consider changing a patient’s weight-management treatment.

Reasons might include:

inadequate treatment response;
side effects;
availability;
patient preference; or
changes in clinical circumstances.

However, you should not switch directly from Wegovy to Mounjaro without medical guidance.

The timing and starting dose of the new medicine need to be considered carefully.

Explore Weight Loss Treatments

Can You Switch From Mounjaro to Wegovy?

Yes, a healthcare professional may consider this in some circumstances.

Again, the switch should be medically managed.

A person who has previously tolerated a higher dose of one medicine should not automatically begin at the equivalent-looking higher dose of another. Mounjaro vs Wegovy.

The medicines use different active ingredients and different dosing schedules.

Can Mounjaro and Wegovy Be Taken Together?

They should not be combined unless specifically directed by an appropriately qualified healthcare professional.

Using multiple medicines acting on similar appetite-regulating pathways can increase risks and has not been established as a routine weight-management strategy.

Do not combine injections independently. Mounjaro vs Wegovy.

Mounjaro vs Wegovy for Type 2 Diabetes

Mounjaro is authorised in the EU for both:

type 2 diabetes; and
weight management under specified conditions.

Wegovy is the semaglutide brand authorised specifically for weight management.

Other semaglutide brands, such as Ozempic, are authorised for diabetes rather than weight management. EMA specifically warns against off-label cosmetic use of diabetes GLP-1 medicines.

That distinction matters when comparing products online. Mounjaro vs Wegovy.

Is Ozempic the Same as Wegovy?

No.

Both contain semaglutide, but they are separate products with different authorised uses and dosing.

EMA identifies:

Wegovy as a weight-management medicine;
Ozempic as a diabetes medicine.

Patients should not assume that medicines containing the same active ingredient are interchangeable.

Is Mounjaro a GLP-1 Medicine?

Mounjaro includes GLP-1 receptor activity, but it is more accurately described as a dual GIP and GLP-1 receptor agonist.

That is what distinguishes tirzepatide from semaglutide.

Which Is Better if I Do Not Like Injections?

Both established Mounjaro and Wegovy weight-management treatments are injectable.

However, oral weight-management options exist. Mounjaro vs Wegovy.

Notably, in May 2026 the EMA’s CHMP recommended an oral daily Wegovy formulation as an alternative to the weekly injection for adults. The oral form is taken once daily on an empty stomach and was described as the first oral GLP-1 treatment developed specifically for weight management.

You can also explore MySlimCare’s weight loss tablets and capsules.

Which Is Better if I Want a Weekly Injection?

Both Mounjaro and injectable Wegovy are used once weekly.

The choice therefore depends less on injection frequency and more on:

active ingredient;
mechanism;
medical history;
expected benefits;
side effects;
availability; and
professional assessment.

Is Mounjaro Better for Appetite Control?

Both medicines influence appetite.

Mounjaro acts through both GIP and GLP-1 pathways, while Wegovy acts through GLP-1.

Individual appetite response differs significantly. Mounjaro vs Wegovy.

It would therefore be misleading to promise that one will always control hunger better for every patient.

Is Wegovy Safer Because It Has Been Used Longer?

Length of market experience is one factor clinicians may consider, but it does not automatically make one medicine safer for a particular person.

Both medicines have been assessed by European regulators and are authorised for their approved indications.

Individual safety depends on medical circumstances. Mounjaro vs Wegovy.

Mounjaro vs Wegovy Cost

Prices can vary significantly by:

country;
dose;
pharmacy;
supply;
healthcare reimbursement;
insurance; and
prescribing arrangements.

Cost should not be the sole reason for choosing a treatment.

A cheaper treatment that is unsuitable or poorly tolerated is not necessarily better value.

For current options, browse the MySlimCare Shop.

Can I Buy Mounjaro or Wegovy Online?

Both are prescription medicines.

EMA states that GLP-1 and related weight-management medicines should only be used under medical supervision and warns about falsified products sold online. Consumers should purchase prescription medicines only through appropriately registered pharmacies and legal supply channels.

MySlimCare should therefore position access around consultation and suitability, not unrestricted online purchase. Mounjaro vs Wegovy.

Which Weight Loss Injection Is Right for Me?

The answer depends on your individual circumstances.

Questions to consider include:

What is your BMI?

Eligibility may depend on BMI and weight-related health conditions.

Do you have diabetes?

This may influence treatment selection.

What medicines do you take?

Potential interactions and overlapping treatments matter.

Have you used GLP-1 medication before?

Previous response and side effects can be relevant.

Which side effects are you most concerned about?

Tolerability varies.

Are you comfortable injecting once weekly?

Both established injectable treatments use a weekly schedule.

Are you planning pregnancy?

This affects suitability and treatment planning.

The final decision should be based on professional assessment rather than internet rankings.

Explore Mounjaro, Wegovy and Other Weight Loss Injections

MySlimCare provides access to information about different weight-management approaches for customers across supported European markets. Mounjaro vs Wegovy.

Browse the MySlimCare Weight Loss Injections category to compare available treatment options.

You can also view the full MySlimCare shop for oral weight-management medicines and other health products.

Mounjaro vs Wegovy FAQs

What is the main difference between Mounjaro and Wegovy?

Mounjaro contains tirzepatide and activates both GIP and GLP-1 receptors. Wegovy contains semaglutide and acts as a GLP-1 receptor agonist.

Are Mounjaro and Wegovy both approved for weight loss in Europe?

Yes. Both are authorised in the EU for weight management in eligible adults alongside a reduced-calorie diet and increased physical activity. Mounjaro vs Wegovy.

Which causes more weight loss, Mounjaro or Wegovy?

Both can produce substantial weight reduction. Mounjaro clinical studies reported average weight reductions of at least 15% depending on dose, but individual results vary and direct comparison requires appropriately designed head-to-head evidence.

Is Mounjaro a GLP-1?

Mounjaro has GLP-1 activity but is more accurately described as a dual GIP and GLP-1 receptor agonist.

Is Wegovy a GLP-1?

Yes. Wegovy contains semaglutide, a GLP-1 receptor agonist.

How often do you inject Mounjaro?

Mounjaro is normally injected once weekly.

How often do you inject Wegovy?

Injectable Wegovy is normally administered once weekly.

Can I switch from Wegovy to Mounjaro?

A healthcare professional may consider a switch in some circumstances, but patients should not change treatments or doses without medical guidance.

Can I take Mounjaro and Wegovy together?

They should not routinely be combined. Do not use them together unless specifically instructed by an appropriately qualified healthcare professional.

Is Ozempic the same as Wegovy?

No. Both contain semaglutide, but Wegovy is authorised for weight management while Ozempic is authorised for diabetes.

Do Mounjaro and Wegovy suppress appetite?

Both influence hormone pathways involved in appetite and fullness, which can help reduce food intake.

Which has fewer side effects?

There is no universal answer. Both commonly cause gastrointestinal effects, and individual tolerability varies.

Can I use Mounjaro or Wegovy for cosmetic weight loss?

No. EMA states that these medicines should not be used for cosmetic weight loss in people who do not meet the authorised obesity or overweight criteria.

Do I need diet and exercise while taking them?

Yes. Both are authorised as adjuncts to a reduced-calorie diet and increased physical activity.

Are Mounjaro and Wegovy prescription medicines?

Yes. Both require a prescription and should be used under medical supervision.